Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase 1/2 2Phase 1 2Phase 2/3 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 32Colonic Neoplasms 8Rectal Neoplasms 7Neoplasm Metastasis 5Stomach Neoplasms 3Pancreatic Neoplasms 3Gallbladder Neoplasms 3Cholangiocarcinoma 3Neutropenia 2Bile Duct Neoplasms 2Adenocarcinoma 2mCRC 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Neoplasms 1Nasopharyngeal Carcinoma 1Microsatellite-stable Colorectal Cancer 1Lung Neoplasms 1High-grade Extra Pulmonary Neuroendocrine Cancer 1Gastric Cancer Adenocarcinoma Metastatic 1First-line Treatment 1Esophageal Squamous Cell Carcinoma 1EFS 1Dihydropyrimidine Dehydrogenase Deficiency 1Clinical Stage III Gastric Cancer AJCC v8 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × trifluridine tipiracil drug combination × Clear all
NCT05476796 2024-10-24

LOGICAN

UNICANCER

Phase 2 Recruiting
118 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Recurrence

NCT02860546 2024-09-03

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC

Taiho Oncology, Inc.

Phase 2 Completed
18 enrolled 12 charts
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03274882 2024-07-25

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

Servier

Phase 2 Completed
26 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT02920476 2022-06-23

UF-STO-LUNG-003

University of Florida

Phase 2 Completed
4 enrolled 8 charts
Tumor-Agnostic

Carcinoma, Neoplasm Metastasis

NCT02921737 2021-02-04

UF-STO-PANC-003

University of Florida

Phase 2 Terminated
7 enrolled 12 charts
Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡